Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Schirinzi

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neurology|August 28, 2020
COVID-19: dealing with a potential risk factor for chronic neurological disordersTommaso Schirinzi, Doriana Landi, Claudio Liguori
Expert Opinion on Pharmacotherapy|May 19, 2023
Pharmacotherapy for Sydenham's chorea: where are we and where do we need to be?Roberta Bovenzi, Matteo Conti, Tommaso Schirinzi
Acta Bio-Medica : Atenei Parmensis|August 29, 2017
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case reportPaola Imbriani, Tommaso Schirinzi, Alessio D'Elia, et al.
Current Opinion in Neurology|May 11, 2018
Dystonia as a network disorder: a concept in evolutionTommaso Schirinzi, Giuseppe Sciamanna, Nicola B Mercuri, et al.
Reviews in the Neurosciences|July 18, 2020
The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisalTommaso Schirinzi, Marco Canevelli, Antonio Suppa, et al.
Parkinsonism & Related Disorders|June 6, 2021
Working memory, attention and planning abilities in NKX2.1-related choreaFederica Graziola, Giacomo Garone, Melissa Grasso, et al.
Current Opinion in Neurobiology|May 26, 2026
Do animal models represent the diversity of clinical Parkinson's disease?Mariangela Massaro Cenere, Tommaso Schirinzi, Ada Ledonne, et al.
Cerebellum (London, England)|November 9, 2019
Speech and Language Disorders in Friedreich Ataxia: Highlights on Phenomenology, Assessment, and TherapyTommaso Schirinzi, Andrea Sancesario, Enrico Bertini, et al.
Cerebellum & Ataxias|January 7, 2021
Friedreich ataxia in COVID-19 time: current impact and future possibilitiesTommaso Schirinzi, Andrea Sancesario, Enrico Castelli, et al.
Parkinsonism & Related Disorders|August 2, 2017
Promising rodent models in Parkinson's diseasePaola Imbriani, Giuseppe Sciamanna, Massimo Santoro, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neurology|August 28, 2020
COVID-19: dealing with a potential risk factor for chronic neurological disordersTommaso Schirinzi, Doriana Landi, Claudio Liguori
Expert Opinion on Pharmacotherapy|May 19, 2023
Pharmacotherapy for Sydenham's chorea: where are we and where do we need to be?Roberta Bovenzi, Matteo Conti, Tommaso Schirinzi
Acta Bio-Medica : Atenei Parmensis|August 29, 2017
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case reportPaola Imbriani, Tommaso Schirinzi, Alessio D'Elia, et al.
Current Opinion in Neurology|May 11, 2018
Dystonia as a network disorder: a concept in evolutionTommaso Schirinzi, Giuseppe Sciamanna, Nicola B Mercuri, et al.
Reviews in the Neurosciences|July 18, 2020
The continuum between neurodegeneration, brain plasticity, and movement: a critical appraisalTommaso Schirinzi, Marco Canevelli, Antonio Suppa, et al.
Parkinsonism & Related Disorders|June 6, 2021
Working memory, attention and planning abilities in NKX2.1-related choreaFederica Graziola, Giacomo Garone, Melissa Grasso, et al.
Current Opinion in Neurobiology|May 26, 2026
Do animal models represent the diversity of clinical Parkinson's disease?Mariangela Massaro Cenere, Tommaso Schirinzi, Ada Ledonne, et al.
Cerebellum (London, England)|November 9, 2019
Speech and Language Disorders in Friedreich Ataxia: Highlights on Phenomenology, Assessment, and TherapyTommaso Schirinzi, Andrea Sancesario, Enrico Bertini, et al.
Cerebellum & Ataxias|January 7, 2021
Friedreich ataxia in COVID-19 time: current impact and future possibilitiesTommaso Schirinzi, Andrea Sancesario, Enrico Castelli, et al.
Parkinsonism & Related Disorders|August 2, 2017
Promising rodent models in Parkinson's diseasePaola Imbriani, Giuseppe Sciamanna, Massimo Santoro, et al.
Pageof 16